Pharma opportunity in India

Indian pharmaceutical companies offer an attractive investment opportunity. India has been in the news with global pharma majors making multi billion dollar acquisitions in India. Investors have also fallen all over each other scrambling to buy the Indian listed arms of multinational pharma companies.

However, the real opportunity is in India's ability to provide low cost drugs. The last decade has seen astonishing growth of several domestic companies that cater to the Indian market. These companies have taken generic formulations (drugs) and produced, packaged and marketed them aggressively in India's hinterland. Some have built businesses in general medicine and others have taken the route of specialized medicine like opthalmology, cardiology, dermatology etc.

India is also emerging a formidable supplier of low cost drugs to CIS countries, Latin America, Africa and the Middle East. Indian companies are big suppliers to World Health Organization (WHO) programmes.

India is also a very high quality and cost efficient manufacturer of generic drugs for developed markets. India has the largest number of US FDA compliant manufacturing facilities outside the US.

VALUEx India being held from 7th-9th November, 2011 in Mumbai will offer an opportunity to learn more about the pharma opportunity in India.